Supplementary Tables 1-4. Supplementary Figure 1 from Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma

Autor: Johanna Bendell, Cathy Eng, Aimee Bence Lin, Richard Beckmann, Sameera Wijayawardana, Ricardo Martinez, Wei Zhang, Lisa Golden, Jeffrey Infante, Funda Meric-Bernstam, Suzanne Jones, William N. William, Howard A. Burris, Stefan C. Grant, Manish Patel, Kathleen Moore, David S. Hong
Rok vydání: 2023
Popis: Supplementary Table S1. JTJA Study Dose Expansion Cohorts; Supplementary Table S2. Baseline Disease Classifications of SCCHN Patients Supplementary Table S3. Treatment-Emergent Adverse Events Related to Study Treatment in >10% of Patients with Any Tumor Type; Supplementary Table S4. Genetic Alterations in Tumors Corresponding to SCC of the Anus (n=14) and SCCHN (n=34); Supplementary Figure S1. Progression-free Survival by HPV Status in Patients with SCCHN.
Databáze: OpenAIRE